Nanexa AB Total Liabilities

Latest as of June 2026: Skr21.81 Million SEK ≈ $2.35 Million USD

Nanexa AB total liabilities. Based on the latest financial reports, Nanexa AB (NANEXA) has total liabilities worth Skr21.81 Million SEK (≈ $2.35 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Nanexa AB liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Nanexa AB (2014–2025)

Total liabilities of Nanexa AB from 2014 to 2025. This chart illustrates how Nanexa AB's total liabilities have evolved over time, based on quarterly financial data.

Nanexa AB Competitors by Total Liabilities

The table below lists competitors of Nanexa AB ranked by their total liabilities.

Company	Country	Total Liabilities
Pyrophyte Acquisition Corp. II NYSE:PAII	USA	$9.56 Million
Yesco Holdings Co. Ltd KO:015360	Korea	₩710.54 Billion
Young Optics Inc TW:3504	Taiwan	NT$1.44 Billion
Gamania Digital Entertainment Co Ltd TWO:6180	Taiwan	NT$3.62 Billion
Tudor Gold Corp V:TUD	Canada	CA$17.37 Million
One Point One Solutions Limited NSE:ONEPOINT	India	Rs3.74 Billion
GemVax&KAEL Co.Ltd KQ:082270	Korea	₩101.65 Billion
BVZ Holding AG SW:BVZN	Switzerland	CHF436.12 Million

Liability Composition Analysis (2014–2025)

This chart breaks down Nanexa AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Nanexa AB balance sheet assets.

Liquidity & Leverage Metrics

Nanexa AB Total Liabilities Ratios Explained

Nanexa AB total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	2.89	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.16	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.14	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Nanexa AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Nanexa AB (2014–2025)

The table below shows the annual total liabilities of Nanexa AB from 2014 to 2025.

Year	Total Liabilities	Change
2025-12-31	Skr36.61 Million ≈ $3.94 Million	+75.21%
2024-12-31	Skr20.90 Million ≈ $2.25 Million	-42.64%
2023-12-31	Skr36.43 Million ≈ $3.92 Million	-40.38%
2022-12-31	Skr61.10 Million ≈ $6.58 Million	+345.88%
2021-12-31	Skr13.70 Million ≈ $1.47 Million	+32.52%
2020-12-31	Skr10.34 Million ≈ $1.11 Million	-2.08%
2019-12-31	Skr10.56 Million ≈ $1.14 Million	-9.05%
2018-12-31	Skr11.61 Million ≈ $1.25 Million	+103.42%
2017-12-31	Skr5.71 Million ≈ $614.26K	+57.47%
2016-12-31	Skr3.62 Million ≈ $390.09K	+109.73%
2015-12-31	Skr1.73 Million ≈ $185.99K	+54.67%
2014-12-31	Skr1.12 Million ≈ $120.25K	--

About Nanexa AB

ST:NANEXA Sweden Drug Manufacturers - Specialty & Generic

Market Cap

$207.21 Million

Skr1.93 Billion SEK

Market Cap Rank

#16218 Global

#268 in Sweden

Share Price

Skr10.42

Change (1 day)

-0.76%

52-Week Range

Skr1.61 - Skr12.16

All Time High

Skr15.20